More emphasis should be put on the advantages of providing HCV care for people who inject drugs in centralised rather than decentralised settings, possibly by expanding harm reduction programmes and… Click to show full abstract
More emphasis should be put on the advantages of providing HCV care for people who inject drugs in centralised rather than decentralised settings, possibly by expanding harm reduction programmes and integrating HCV services.
               
Click one of the above tabs to view related content.